Buscar
Telix Pharmaceuticals Ltd
TLXAñadir a la lista de seguimiento
11.280USD
-0.670-5.61%
Horarios del mercado 09/23, 12:33（ET）
0.00Cap. mercado
0.00P/E TTM
Acerca de Telix Pharmaceuticals Ltd Compañía
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Perfil de Telix Pharmaceuticals Ltd
Símbolo de cotizaciónTLX
Nombre de la empresaTelix Pharmaceuticals Ltd
Fecha de salida a bolsaNov 15, 2017
Director ejecutivoOrtiz (Raphaeel)
Número de empleados- -
Tipo de seguridadDepository Receipt
Fin del año fiscal- -
Dirección55 Flemington Road
CiudadMELBOURNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísAustralia
Código postal3051
Teléfono61390933855
Sitio Webhttps://telixpharma.com/
Símbolo de cotizaciónTLX
Fecha de salida a bolsaNov 15, 2017
Director ejecutivoOrtiz (Raphaeel)
Ejecutivos de Telix Pharmaceuticals Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Christian P. (Chris) Behrenbruch, J.D., Ph.D.
Dr. Christian P. (Chris) Behrenbruch, J.D., Ph.D.
Group Chief Executive Officer, Managing Director, Executive Director
Group Chief Executive Officer, Managing Director, Executive Director
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Jann Skinner
Ms. Jann Skinner
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Cade, M.D.
Dr. David Cade, M.D.
Group Chief Medical Officer
Group Chief Medical Officer
--
--
Mr. Darren Smith, CPA
Mr. Darren Smith, CPA
Group Chief Financial Officer
Group Chief Financial Officer
--
--
Dr. Darren Patti, Pharm.D.
Dr. Darren Patti, Pharm.D.
Group Chief Operating Officer
Group Chief Operating Officer
--
--
Ms. Marie McDonald
Ms. Marie McDonald
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David Gill
Mr. David Gill
Non-Executive Chair of the Board
Non-Executive Chair of the Board
--
--
Ms. Shomalin Naidoo
Ms. Shomalin Naidoo
Interim Company Secretary
Interim Company Secretary
--
--
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Additional Non-Executive Director
Additional Non-Executive Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Christian P. (Chris) Behrenbruch, J.D., Ph.D.
Dr. Christian P. (Chris) Behrenbruch, J.D., Ph.D.
Group Chief Executive Officer, Managing Director, Executive Director
Group Chief Executive Officer, Managing Director, Executive Director
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Jann Skinner
Ms. Jann Skinner
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Cade, M.D.
Dr. David Cade, M.D.
Group Chief Medical Officer
Group Chief Medical Officer
--
--
Mr. Darren Smith, CPA
Mr. Darren Smith, CPA
Group Chief Financial Officer
Group Chief Financial Officer
--
--
Dr. Darren Patti, Pharm.D.
Dr. Darren Patti, Pharm.D.
Group Chief Operating Officer
Group Chief Operating Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Telix Pharmaceuticals Ltd?
Los cinco principales accionistas de Telix Pharmaceuticals Ltd son: Dr. Christian P. (Chris) Behrenbruch, J.D., Ph.D.
¿Cuántas instituciones poseen acciones de Telix Pharmaceuticals Ltd (TLX)?
A fecha de 2026Q1, 61 instituciones poseen acciones de Telix Pharmaceuticals Ltd, con un valor de mercado combinado de aproximadamente 1.47M, lo que representa el 0.43% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 326197.00.